Provided by Tiger Trade Technology Pte. Ltd.

Creative Medical Technology Holdings, Inc.

1.31
+0.03002.34%
Post-market: 1.320.0117+0.89%19:59 EDT
Volume:548.95K
Turnover:698.67K
Market Cap:8.64M
PE:-0.67
High:1.35
Open:1.27
Low:1.22
Close:1.28
52wk High:6.25
52wk Low:0.6200
Shares:6.59M
Float Shares:6.33M
Volume Ratio:0.22
T/O Rate:8.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9543
EPS(LYR):-2.5200
ROE:-77.88%
ROA:-47.32%
PB:1.00
PE(LYR):-0.52

Loading ...

Roth believes Creative Medical’s ADAPT trial in CLBO ‘likely to succeed’

TIPRANKS
·
Aug 21

Creative Medical Completes Enrollment, Treatment in FDA-Cleared ADAPT Trial of Olastrocel for Chronic Lower Back Pain

Reuters
·
Aug 20

Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared Adapt Trial, Including Opioid Cohort, Advancing Celz-201 / Olastrocel Toward Rmat Evaluation and Phase 3 Planning

THOMSON REUTERS
·
Aug 20

Creative Medical Technology Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 08

Creative Medical Net Loss Widens 22.5% to $1.51 Million in Q2 2026

Reuters
·
Aug 08

NASDAQ Trade Halt Volatility Trading Pause at 10:50 Am

Reuters
·
Aug 06

Creative Medical receives notice of allowance for new U.S. patent

TIPRANKS
·
Aug 06

Creative Medical Technology - Patent to Extend Ip Protection for Myelocelz Platform in Type 1 Diabetes

THOMSON REUTERS
·
Aug 06

Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms

GlobeNewswire
·
Aug 06

Top Premarket Gainers

MT Newswires Live
·
Aug 06

Creative Medical Technology Holdings Inc Expected to Post a Loss of 39 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Creative Medical Technology Holdings Issues Mid-year Update

THOMSON REUTERS
·
Jul 01

Creative Medical Technology Holdings Issues Mid-Year Update

GlobeNewswire
·
Jul 01

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds

THOMSON REUTERS
·
Jul 01

Top Premarket Decliners

MT Newswires Live
·
Jun 26

Creative Medical Files for Securities Offering

MT Newswires Live
·
Jun 26

Creative Medical files to sell 3.05M shares of common stock

TIPRANKS
·
Jun 26

Creative Medical expands ADAPT trial under new FDA clearance

TIPRANKS
·
Jun 22

Creative Medical wins FDA clearance to expand ADAPT trial of Olastrocel in chronic lower back pain

Reuters
·
Jun 22

Creative Medical Technology Holdings Expands Adapt Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain

THOMSON REUTERS
·
Jun 22